TickerFactsScreenerDevelopers

UroGen Pharma Ltd. (URGN) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$7.17M2016: $4.19M2017: -$9.57M2018: -$37.33M2019: -$71.02M2020: -$105.89M2021: -$84.89M2022: -$87.56M2023: -$76.38M2024: -$96.77M2025: -$162.44M-$162.44M
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$162.44M-67.9%
2024-$96.77M-26.7%
2023-$76.38M+12.8%
2022-$87.56M-3.1%
2021-$84.89M+19.8%
2020-$105.89M-49.1%
2019-$71.02M-90.2%
2018-$37.33M-290.2%
2017-$9.57M-328.4%
2016$4.19M+158.4%
2015-$7.17M—